Advertisement
Screener

ELI LILLY AND COMPANY (LLY) Repayments of Long-Term Debt

2.8 / 5 stars · 68/120 Roast Me

ELI LILLY AND COMPANY Repayments of Long-Term Debt

ELI LILLY AND COMPANY (LLY) reported Repayments of Long-Term Debt of $1.62 billion for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Cash Flow › Financing Activities

us-gaap:RepaymentsOfLongTermDebt · last filed 2026-08-05

  • ELI LILLY AND COMPANY repayments of long-term debt for the quarter ending 2026-06-30 was $873.00M, a 12.21% increase year-over-year.
  • ELI LILLY AND COMPANY repayments of long-term debt for the quarter ending 2026-03-31 was $750.00M.
  • ELI LILLY AND COMPANY repayments of long-term debt for the quarter ending 2025-12-31 was -$100.00K.
  • ELI LILLY AND COMPANY repayments of long-term debt for the quarter ending 2025-09-30 was $100.00K.
  • ELI LILLY AND COMPANY repayments of long-term debt for fiscal 2025 was $778.00M, a 17.17% increase from fiscal 2024.
  • ELI LILLY AND COMPANY repayments of long-term debt for fiscal 2024 was $664.00M.
  • ELI LILLY AND COMPANY repayments of long-term debt for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
  • ELI LILLY AND COMPANY repayments of long-term debt for fiscal 2022 was $1.56B, a 18.13% decline from fiscal 2021.
Period endRepayments of Long-term Debt 3 monthRepayments of Long-term Debt 3 month as first filedRepayments of Long-term Debt 6 monthRepayments of Long-term Debt 6 month as first filedRepayments of Long-term Debt 9 monthRepayments of Long-term Debt 9 month as first filedRepayments of Long-term Debt 12 monthRepayments of Long-term Debt 12 month as first filed
2026-06-30$873.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$1.62B
10-Q · filed 2026-08-05
$1.62B
derived: sum of 3 quarters · filed 2026-08-05
$1.62B
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31$750.00M
10-Q · filed 2026-04-30
$749.90M
derived: sum of 2 quarters · filed 2026-04-30
$750.00M
derived: sum of 3 quarters · filed 2026-04-30
$1.53B
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31-$100.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$0.00
derived: sum of 2 quarters · filed 2026-02-12
$778.00M
derived: sum of 3 quarters · filed 2026-08-05
$778.00M
10-K · filed 2026-02-12
2025-09-30$100.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$778.10M
derived: sum of 2 quarters · filed 2026-08-05
$778.10M
10-Q · filed 2025-10-30
$777.90M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$778.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05
$778.00M
10-Q · filed 2026-08-05
$778.10M
10-Q · filed 2025-08-07
$777.80M
derived: sum of 3 quarters · filed 2026-08-05
$777.80M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31$0.00
10-Q · filed 2026-04-30
-$200.00K
derived: sum of 2 quarters · filed 2026-04-30
-$200.00K
derived: sum of 3 quarters · filed 2026-04-30
2024-12-31-$200.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
-$200.00K
derived: sum of 2 quarters · filed 2026-02-12
$664.00M
10-K · filed 2026-02-12
$664.20M
10-K · filed 2025-02-19
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$664.20M
10-Q · filed 2025-10-30
2024-06-30$664.20M
10-Q · filed 2025-08-07
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$0.00
derived: sum of 2 quarters · filed 2026-02-12
$0.00
derived: sum of 3 quarters · filed 2026-02-12
$0.00
10-K · filed 2026-02-12
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30
$0.00
derived: sum of 2 quarters · filed 2024-10-30
$0.00
10-Q · filed 2024-10-30
$0.00
derived: sum of 4 quarters · filed 2025-02-19
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$0.00
10-Q · filed 2024-08-08
$0.00
derived: sum of 3 quarters · filed 2025-02-19
$0.00
derived: sum of 4 quarters · filed 2025-02-19
2023-03-31$0.00
10-Q · filed 2023-04-27
$0.00
derived: sum of 2 quarters · filed 2025-02-19
$0.00
derived: sum of 3 quarters · filed 2025-02-19
$849.90M
derived: sum of 4 quarters · filed 2025-02-19
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19
$0.00
derived: sum of 2 quarters · filed 2025-02-19
$849.90M
derived: sum of 3 quarters · filed 2025-02-19
$1.56B
10-K · filed 2025-02-19
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02
$849.90M
derived: sum of 2 quarters · filed 2023-11-02
$1.56B
10-Q · filed 2023-11-02
$1.56B
derived: sum of 4 quarters · filed 2024-02-21
2022-06-30$849.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$1.56B
10-Q · filed 2023-08-08
$1.56B
derived: sum of 3 quarters · filed 2024-02-21
$3.47B
derived: sum of 4 quarters · filed 2024-02-21
2022-03-31$710.10M
10-Q · filed 2023-04-27
$710.20M
derived: sum of 2 quarters · filed 2024-02-21
$2.62B
derived: sum of 3 quarters · filed 2024-02-21
$2.62B
derived: sum of 4 quarters · filed 2024-02-21
2021-12-31$100.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21
$1.91B
derived: sum of 2 quarters · filed 2024-02-21
$1.91B
derived: sum of 3 quarters · filed 2024-02-21
$1.91B
10-K · filed 2024-02-21
2021-09-30$1.91B
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01
$1.91B
derived: sum of 2 quarters · filed 2022-11-01
$1.91B
10-Q · filed 2022-11-01
$1.91B
derived: sum of 4 quarters · filed 2023-02-22
2021-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$0.00
10-Q · filed 2022-08-04
$200.00K
derived: sum of 3 quarters · filed 2023-02-22
$200.00K
derived: sum of 4 quarters · filed 2023-02-22
2021-03-31$0.00
10-Q · filed 2022-04-29
$200.00K
derived: sum of 2 quarters · filed 2023-02-22
$200.00K
derived: sum of 3 quarters · filed 2023-02-22
$200.00K
derived: sum of 4 quarters · filed 2023-02-22
2020-12-31$200.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22
$200.00K
derived: sum of 2 quarters · filed 2023-02-22
$200.00K
derived: sum of 3 quarters · filed 2023-02-22
$276.50M
10-K · filed 2023-02-22
2020-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27
$0.00
derived: sum of 2 quarters · filed 2021-10-27
$276.30M
10-Q · filed 2021-10-27
$2.54B
derived: sum of 4 quarters · filed 2022-02-23
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03
$276.30M
10-Q · filed 2021-08-03
$2.54B
derived: sum of 3 quarters · filed 2022-02-23
$2.54B
derived: sum of 4 quarters · filed 2022-02-23
2020-03-31$276.30M
10-Q · filed 2021-04-30
$2.54B
derived: sum of 2 quarters · filed 2022-02-23
$2.54B
derived: sum of 3 quarters · filed 2022-02-23
$2.54B
derived: sum of 4 quarters · filed 2022-02-23
2019-12-31$2.27B
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23
$2.27B
derived: sum of 2 quarters · filed 2022-02-23
$2.27B
derived: sum of 3 quarters · filed 2022-02-23
$2.87B
10-K · filed 2022-02-23
2019-09-30$100.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28
$300.00K
derived: sum of 2 quarters · filed 2020-10-28
$600.30M
10-Q · filed 2020-10-28
$607.90M
derived: sum of 4 quarters · filed 2021-02-17
2019-06-30$200.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31
$600.20M
10-Q · filed 2020-07-31
$607.80M
derived: sum of 3 quarters · filed 2021-02-17
$607.80M
derived: sum of 4 quarters · filed 2021-02-17
2019-03-31$600.00M
10-Q · filed 2020-05-01
$607.60M
derived: sum of 2 quarters · filed 2021-02-17
$607.60M
derived: sum of 3 quarters · filed 2021-02-17
$808.80M
derived: sum of 4 quarters · filed 2021-02-17
2018-12-31$7.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17
$7.60M
derived: sum of 2 quarters · filed 2021-02-17
$208.80M
derived: sum of 3 quarters · filed 2021-02-17
$1.01B
10-K · filed 2021-02-17
2018-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-25
$201.20M
derived: sum of 2 quarters · filed 2019-10-25
$1.00B
10-Q · filed 2019-10-25
$1.00B
derived: sum of 4 quarters · filed 2020-02-19
2018-06-30$201.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02
$1.00B
10-Q · filed 2019-08-02
$1.00B
derived: sum of 3 quarters · filed 2020-02-19
$1.00B
derived: sum of 4 quarters · filed 2020-02-19
2018-03-31$800.30M
10-Q · filed 2019-05-02
$800.30M
derived: sum of 2 quarters · filed 2020-02-19
$800.40M
derived: sum of 3 quarters · filed 2020-02-19
$800.70M
derived: sum of 4 quarters · filed 2020-02-19
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19
$100.00K
derived: sum of 2 quarters · filed 2020-02-19
$400.00K
derived: sum of 3 quarters · filed 2020-02-19
$630.60M
10-K · filed 2020-02-19
2017-09-30$100.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
$400.00K
derived: sum of 2 quarters · filed 2018-11-06
$630.60M
10-Q · filed 2018-11-06
$630.60M
derived: sum of 4 quarters · filed 2019-10-24
2017-06-30$300.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-25
$630.50M
10-Q · filed 2018-07-25
$630.50M
derived: sum of 3 quarters · filed 2019-10-24
$630.60M
derived: sum of 4 quarters · filed 2019-10-24
2017-03-31$630.20M
10-Q · filed 2018-04-27
$630.20M
derived: sum of 2 quarters · filed 2019-10-24
$630.30M
derived: sum of 3 quarters · filed 2019-10-24
$630.40M
derived: sum of 4 quarters · filed 2019-10-24
2016-12-31$0.00
derived: 8-K 12 month − 10-Q 9 month · filed 2019-10-24
$100.00K
derived: sum of 2 quarters · filed 2019-10-24
$200.00K
derived: sum of 3 quarters · filed 2019-10-24
$200.00K
8-K · filed 2019-10-24
2016-09-30$100.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27
$200.00K
derived: sum of 2 quarters · filed 2017-10-27
$200.00K
10-Q · filed 2017-10-27
$5.30M
derived: sum of 4 quarters · filed 2018-02-20
2016-06-30$100.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28
$100.00K
10-Q · filed 2017-07-28
$5.20M
derived: sum of 3 quarters · filed 2018-02-20
$6.60M
derived: sum of 4 quarters · filed 2018-02-20
2016-03-31$0.00
10-Q · filed 2017-05-01
$5.10M
derived: sum of 2 quarters · filed 2018-02-20
$6.50M
derived: sum of 3 quarters · filed 2018-02-20
$1.96B
derived: sum of 4 quarters · filed 2018-02-20
2015-12-31$5.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20
$6.50M
derived: sum of 2 quarters · filed 2018-02-20
$1.96B
derived: sum of 3 quarters · filed 2018-02-20
$1.96B
10-K · filed 2018-02-20
2015-09-30$1.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28
$1.95B
derived: sum of 2 quarters · filed 2018-02-20
$1.95B
10-Q · filed 2016-10-28
$1.95B
derived: sum of 4 quarters · filed 2018-02-20
2015-06-30$1.95B
10-K · filed 2018-02-20
$1.95B
10-Q · filed 2016-07-28
$1.95B
derived: sum of 3 quarters · filed 2018-02-20
$1.95B
derived: sum of 4 quarters · filed 2018-02-20
2015-03-31$1.50M
10-Q · filed 2015-04-30
$2.00M
derived: sum of 2 quarters · filed 2017-02-21
$2.50M
derived: sum of 3 quarters · filed 2017-02-21
$36.30M
derived: sum of 4 quarters · filed 2017-02-21
2014-12-31$500.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-21
$1.00M
derived: sum of 2 quarters · filed 2017-02-21
$34.80M
derived: sum of 3 quarters · filed 2017-02-21
$1.03B
10-K · filed 2017-02-21
2014-09-30$500.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-30
$34.30M
derived: sum of 2 quarters · filed 2015-10-30
$1.03B
10-Q · filed 2015-10-30
$1.04B
derived: sum of 4 quarters · filed 2017-02-21
2014-06-30$33.80M
derived: 10-Q 6 month − 10-K 3 month · filed 2015-07-30
$1.03B
10-Q · filed 2015-07-30
$1.04B
derived: sum of 3 quarters · filed 2017-02-21
$1.04B
derived: sum of 4 quarters · filed 2017-02-21
2014-03-31$1.00B
10-K · filed 2017-02-21
$1.00B
10-Q · filed 2014-04-28
$1.01B
derived: sum of 2 quarters · filed 2017-02-21
$1.01B
derived: sum of 3 quarters · filed 2017-02-21
$1.01B
derived: sum of 4 quarters · filed 2017-02-21
2013-12-31$7.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19
$8.80M
derived: sum of 2 quarters · filed 2016-02-19
$9.60M
derived: sum of 3 quarters · filed 2016-02-19
$10.50M
10-K · filed 2016-02-19
2013-09-30$1.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29
$2.10M
derived: sum of 2 quarters · filed 2014-10-29
$3.00M
10-Q · filed 2014-10-29
$5.60M
derived: sum of 4 quarters · filed 2015-02-19
2013-06-30$800.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-28
$1.70M
10-Q · filed 2014-07-28
$4.30M
derived: sum of 3 quarters · filed 2015-02-19
$4.80M
derived: sum of 4 quarters · filed 2015-02-19
2013-03-31$900.00K
10-Q · filed 2014-04-28
$3.50M
derived: sum of 2 quarters · filed 2015-02-19
$4.00M
derived: sum of 3 quarters · filed 2015-02-19
$4.90M
derived: sum of 4 quarters · filed 2015-02-19
2012-12-31$2.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19
$3.10M
derived: sum of 2 quarters · filed 2015-02-19
$4.00M
derived: sum of 3 quarters · filed 2015-02-19
$1.51B
10-K · filed 2015-02-19
$1.50B
10-K · filed 2013-02-21
2012-09-30$500.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30
$1.40M
derived: sum of 2 quarters · filed 2013-10-30
$1.51B
10-Q · filed 2013-10-30
$1.50B
10-Q · filed 2012-10-26
$1.52B
derived: sum of 4 quarters · filed 2014-02-19
2012-06-30$900.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-07-26
$1.51B
10-Q · filed 2013-07-26
$1.50B
10-Q · filed 2012-07-27
$1.52B
derived: sum of 3 quarters · filed 2014-02-19
$1.52B
derived: sum of 4 quarters · filed 2014-02-19
2012-03-31$1.51B
10-Q · filed 2013-04-26
$1.50B
10-Q · filed 2012-04-30
$1.51B
derived: sum of 2 quarters · filed 2014-02-19
$1.51B
derived: sum of 3 quarters · filed 2014-02-19
$1.51B
derived: sum of 4 quarters · filed 2014-02-19
2011-12-31$7.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-19
$7.10M
derived: sum of 2 quarters · filed 2014-02-19
$7.10M
derived: sum of 3 quarters · filed 2014-02-19
$61.70M
10-K · filed 2014-02-19
$54.60M
10-K · filed 2012-02-24
2011-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-26
$0.00
derived: sum of 2 quarters · filed 2012-10-26
$54.60M
10-Q · filed 2012-10-26
$55.00M
derived: sum of 4 quarters · filed 2013-02-21
2011-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-27
$54.60M
10-Q · filed 2012-07-27
$55.00M
derived: sum of 3 quarters · filed 2013-02-21
$56.40M
derived: sum of 4 quarters · filed 2013-02-21
2011-03-31$54.60M
10-Q · filed 2012-04-30
$55.00M
derived: sum of 2 quarters · filed 2013-02-21
$56.40M
derived: sum of 3 quarters · filed 2013-02-21
$55.70M
derived: sum of 4 quarters · filed 2013-02-21
2010-12-31$400.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21
$1.80M
derived: sum of 2 quarters · filed 2013-02-21
$1.10M
derived: sum of 3 quarters · filed 2013-02-21
$1.10M
10-K · filed 2013-02-21
2010-09-30$1.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28
$700.00K
derived: sum of 2 quarters · filed 2011-10-28
$700.00K
10-Q · filed 2011-10-28
-$399.30M
derived: sum of 4 quarters · filed 2012-02-24
2010-06-30-$700.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-29
-$700.00K
10-Q · filed 2011-07-29
-$400.70M
derived: sum of 3 quarters · filed 2012-02-24
-$700.00K
derived: sum of 4 quarters · filed 2012-02-24
2010-03-31$0.00
10-Q · filed 2011-04-29
-$400.00M
derived: sum of 2 quarters · filed 2012-02-24
$0.00
derived: sum of 3 quarters · filed 2012-02-24
2009-12-31-$400.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-24
$0.00
derived: sum of 2 quarters · filed 2012-02-24
$0.00
10-K · filed 2012-02-24
2009-09-30$400.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2010-10-29
$400.00M
10-Q · filed 2010-10-29
-$400.00M
10-Q · filed 2009-10-30
2009-06-30$0.00
10-Q · filed 2009-07-31
2008-12-31$660.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-22
$657.20M
derived: sum of 2 quarters · filed 2011-02-22
$649.80M
10-K · filed 2011-02-22
2008-09-30-$3.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2009-10-30
-$10.80M
10-Q · filed 2009-10-30
2008-06-30-$7.40M
10-Q · filed 2009-07-31
2007-12-31$1.06B
10-K · filed 2010-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Akari Therapeutics Plc (AKTX)$1,527.991B-47,921.42
JOHNSON & JOHNSON (JNJ)United States$652.528B29.10
AbbVie Inc. (ABBV)United States$468.180B70.37
Merck & Co., Inc. (MRK)United States$365.215B99.96
ABBOTT LABORATORIES (ABT)United States$176.045B28.47
PFIZER INC (PFE)United States$162.042B31.94
VERTEX PHARMACEUTICALS INC / MA (VRTX)United States$132.481B28.56
BRISTOL MYERS SQUIBB CO (BMY)United States$125.637B12.67
REGENERON PHARMACEUTICALS, INC. (REGN)United States$74.751B21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)United States$33.420B54.94